Effectiveness and Safety of Bu Shen Kai Qiao Fang in the Treatment of Alzheimer’s Disease: Study Protocol for a Multicenter, Prospective, Real-World Clinical Trial

References

• Feng YS, Tan ZX, Wu LY, Dong F, Zhang F. The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease. Ageing Res Rev. 2020;64:101192.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Status Report on the Public Health Response to Dementia. World Health Organization; 2021.
   Google Scholar
• Zhang Y, Li Y, Ma L. Recent advances in research on Alzheimer’s disease in China. J Clin Neurosci. 2020;2020:81.
   Google Scholar
• As Association. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(3):327–406. doi:10.1002/alz.12328
   PubMed Web of Science ®Google Scholar
• Grossberg GT, Tong G, Burke AD, Tariot PN. Present algorithms and future treatments for Alzheimer’s disease. J Alzheimers Dis. 2019;67(4):1157–1171. doi:10.3233/JAD-180903
   PubMed Web of Science ®Google Scholar
• As Association. 2020 Alzheimer’s disease facts and figures. Alzheimers Dement. 2020;2020:1.
   Google Scholar
• Hane FT, Lee BY, Leonenko Z. Recent progress in Alzheimer’s disease research, part 1: pathology. J Alzheimers Dis. 2017;57(1):1–28. doi:10.3233/JAD-160882
   PubMed Web of Science ®Google Scholar
• Pei H, Ma L, Cao Y, et al. Traditional Chinese medicine for Alzheimer’s disease and other cognitive impairment: a review. Am J Chinese Med. 2020;48(3):487–511. doi:10.1142/S0192415X20500251
   PubMed Web of Science ®Google Scholar
• Klimova B, Kuca K. Alzheimer’s disease and Chinese medicine as a useful alternative intervention tool: a mini-review. Curr Alzheimer Res. 2017;14(6):680–685. doi:10.2174/1567205014666170117103656
   PubMed Web of Science ®Google Scholar
• Shi J, Ni J, Lu T, et al. Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer’s disease: a retrospective analysis. BMC Complem Altern M. 2017;17(1):533. doi:10.1186/s12906-017-2040-5
   PubMedGoogle Scholar
• Li Ou ZJXJ. Effect of Xiangxuan Yishen prescription on neuronal apoptosis in vascular dementia rats. Shaanxi J Tradit Chin Med. 2021;42(6):687–691.
   Google Scholar
• World MA. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama J Am Med Assoc. 2013;310:20.
   Web of Science ®Google Scholar
• Administration NMP. Good clinical practice 2020; 2020.
   Google Scholar
• JinZhou T, HengGe X, LuNing W, et al. Chinese guidelines for the diagnosis and treatment of Alzheimer’s disease Dementia(2020). Chin J Geriatr. 2021;40:3.
   Google Scholar
• Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279. doi:10.1016/j.jalz.2011.03.008
   PubMed Web of Science ®Google Scholar
• Zheng YY. Guidelines for Clinical Research of Chinese Medicine (New Drug). Beijing, China: Chinese Medicine and Science Publication House; 2002.
   Google Scholar
• Zhang YL. International clinical practice guide for traditional Chinese medicine Alzheimer disease(2019-10-11). World Chin Med. 2021;16(08):1181–1187.
   Google Scholar
• Folstein MF, Folstein SE, McHugh PR. ”Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi:10.1016/0022-3956(75)90026-6
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
   PubMed Web of Science ®Google Scholar
• Chen TB, Lai YH, Ke TL, et al. Changes in plasma amyloid and tau in a longitudinal study of normal aging, mild cognitive impairment, and Alzheimer’s disease. Dement Geriatr Cogn. 2019;48(3–4):180–195. doi:10.1159/000505435
   PubMed Web of Science ®Google Scholar
• Mielke MM, Hagen CE, Wennberg A, et al. Association of plasma total tau level with cognitive decline and risk of mild cognitive impairment or dementia in the mayo clinic study on aging. Jama Neurol. 2017;74(9):1073–1080. doi:10.1001/jamaneurol.2017.1359
   PubMed Web of Science ®Google Scholar
• Zhao S, Zhang L, Yang C, Li Z, Rong S. Procyanidins and Alzheimer’s Disease. Mol Neurobiol. 2019;56(8):5556–5567. doi:10.1007/s12035-019-1469-6
   PubMed Web of Science ®Google Scholar
• Yang G, Wang Y, Tian J, Liu JP. Huperzine A for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trials. PLoS One. 2013;8(9):e74916. doi:10.1371/journal.pone.0074916
   PubMed Web of Science ®Google Scholar
• Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and antioxidant effect of ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics. 2019;16(3):666–674. doi:10.1007/s13311-019-00767-8
   PubMed Web of Science ®Google Scholar
• Gregory J, Vengalasetti YV, Bredesen DE, Rao RV. Neuroprotective herbs for the management of Alzheimer’s disease. Biomolecules. 2021;11(4):543. doi:10.3390/biom11040543
   PubMed Web of Science ®Google Scholar
• Zhao YN, Wu XG, Li JM, Chen CX, Rao YZ, Li SX. 中药补阳还五汤对沙鼠脑缺血再灌注损伤及微循环障碍的治疗作用 [Effect of BuYangHuanWu recipe on cerebral microcirculation in gerbils with ischemia-reperfusion]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010;41(1):53–56. Chinese.
   PubMedGoogle Scholar
• Kim MS, Bang JH, Lee J, et al. Salvia miltiorrhiza extract protects white matter and the hippocampus from damage induced by chronic cerebral hypoperfusion in rats. BMC COMPLEM ALTERN M. 2015;15:415. doi:10.1186/s12906-015-0943-6
   PubMed Web of Science ®Google Scholar
• Zhang ZL, Gao YG, Zang P, et al. 天麻素对羟基苯甲醇对中枢神经系统作用机制研究进展 [Research progress on mechanism of gastrodin and p-hydroxybenzyl alcohol on central nervous system]. Zhongguo Zhong Yao Za Zhi. 2020;45(2):312–320. Chinese. doi:10.19540/j.cnki.cjcmm.20190730.401
   PubMedGoogle Scholar
• Lin LW, Tsai FH, Lan WC, Cheng YD, Lee SC, Wu CR. Steroid-enriched fraction of achyranthes bidentata protects amyloid beta peptide 1-40-induced cognitive dysfunction and neuroinflammation in rats. Mol Neurobiol. 2019;56(8):5671–5688. doi:10.1007/s12035-018-1436-7
   PubMed Web of Science ®Google Scholar
• Wei S. Potential therapeutic action of natural products from traditional Chinese medicine on Alzheimer’s disease animal models targeting neurotrophic factors. Fund Clin Pharmacol. 2016;30(6):490–501. doi:10.1111/fcp.12222
   PubMed Web of Science ®Google Scholar
• Mikami M, Takuya O, Yoshino Y, et al. Acorus calamus extract and its component alpha-asarone attenuate murine hippocampal neuronal cell death induced by l-glutamate and tunicamycin. Biosci Biotech Bioch. 2021;85(3):493–501. doi:10.1093/bbb/zbaa071
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu Z, Pi Z, Song F, Wu J, Liu S. Poria cocos could ameliorate cognitive dysfunction in APP/PS1 mice by restoring imbalance of Aβ production and clearance and gut microbiota dysbiosis. Phytother Res. 2021;35:2678–2690. doi:10.1002/ptr.7014
   PubMed Web of Science ®Google Scholar
• Li J, Du Q, Li N, Du S, Sun Z. Alpiniae oxyphyllae Fructus and Alzheimer’s disease: an update and current perspective on this traditional Chinese medicine. Bio Pharmacoth. 2021;135:111167. doi:10.1016/j.biopha.2020.111167
   PubMed Web of Science ®Google Scholar
• Khan S, Barve KH, Kumar MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer’s disease. Curr Neuropharmacol. 2020;18(11):1106–1125. doi:10.2174/1570159X18666200528142429
   PubMed Web of Science ®Google Scholar
• Illan-Gala I, Lleo A, Karydas A, et al. Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer disease. Neurology. 2021;96(5):e671–e683. doi:10.1212/WNL.0000000000011226
   PubMed Web of Science ®Google Scholar
• Janelidze S, Stomrud E, Palmqvist S, et al. Plasma beta-amyloid in Alzheimer’s disease and vascular disease. Sci Rep. 2016;6:26801. doi:10.1038/srep26801
   PubMed Web of Science ®Google Scholar
• Grapow MT, von Wattenwyl R, Guller U, Beyersdorf F, Zerkowski HR. Randomized controlled trials do not reflect reality: real-world analyses are critical for treatment guidelines. J Thorac Cardiov Sur. 2006;132(1):5–7. doi:10.1016/j.jtcvs.2006.03.035
   PubMed Web of Science ®Google Scholar
• Price D, Brusselle G, Roche N, Freeman D, Chisholm A. Real-world research and its importance in respiratory medicine. Breathe. 2015;11(1):26–38. doi:10.1183/20734735.015414
   Google Scholar
• Knottnerus JA, Tugwell P. Real world research. J Clin Epidemiol. 2010;63(10):1051–1052. doi:10.1016/j.jclinepi.2010.08.001
   PubMed Web of Science ®Google Scholar
• Ford I, Norrie J. Pragmatic Trials. New Engl J Med. 2016;375(5):454–463. doi:10.1056/NEJMra1510059
   PubMed Web of Science ®Google Scholar
• Kremers HM. Methods to analyze real-world databases and registries. Bull Nyu Hosp J Dis. 2009;67(2):193–197.
   PubMedGoogle Scholar